SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amp (AMP) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Amp has a current supply of 99,720,267,351.28921674 with 89,781,193,103.18022 in circulation. The last known price of Amp is 0.0006528 USD and is up 0.85 over the last 24 hours. It is currently trading on 193 active market(s) with $5,174,420.89 traded over the last 24 hours. More information can be found at https://amp.xyz.

AMP Token

A sharp rally and rising volume have put AMP in focus, with traders watching for a breakout and debating whether its strength amid weakness elsewhere in crypto can hold. Bulls point to the Flexa payment-infrastructure thesis and Anvil developments, while skeptics say the move may be another short-lived pump and question whether real-world usage or a confirmed catalyst will follow.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotify shares are drawing attention after rising despite missing headline revenue and EPS estimates, as traders focus on stronger premium-subscriber additions, gross-margin performance and a stronger fourth-quarter profit outlook. Bulls emphasize the guidance and growth, while skeptics point to rising expenses, weaker cash flow and valuation.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has raised concerns about competition for Precigens PAPZIMEOS. Traders are split over whether PGENs first-mover position and established commercial and reimbursement setup outweigh the rivals potential treatment advantages and its accelerated-approval requirements.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention amid a pullback in mega-cap tech and concerns that heavy AI infrastructure spending could strain cash flow before delivering returns. Traders debate whether this signals a broader breakdown or a buying opportunity near support, with some pointing to rotation among tech leaders.

World Liberty Financial (WLFI) is a cryptocurrency launched in 2025and operates on the Ethereum platform. World Liberty Financial has a current supply of 100,000,000,000 with 31,779,981,969 in circulation. The last known price of World Liberty Financial is 0.05006283 USD and is down -1.40 over the last 24 hours. It is currently trading on 491 active market(s) with $50,711,301.08 traded over the last 24 hours. More information can be found at https://www.worldlibertyfinancial.com/.

WorldFinancial

Debate over the Trump familys reported crypto earnings and WLFI-related sales is fueling concern that insiders profited while token holders absorbed losses, with many traders calling the project a scam. Bulls counter that a bank charter and future USD1 utility could support a recovery, though those catalysts and their impact remain uncertain.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadogs post-earnings selloff is the dominant focus: traders point to slower forward growth expectations and a major AI customers planned usage reduction, despite a strong reported quarter and raised outlook. The debate centers on whether the reaction is an overdone response to high expectations or a warning about usage-driven growth and the stocks rich valuation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a fresh 52-week high and heavy call-option activity have fueled buyout speculation, especially around Sanofis stated openness to larger acquisitions, though no deal is confirmed. Traders are also watching the upcoming Q3 report and BRIUMVIs sales ramp, while debating whether the rally has already priced in good news.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is pursuing access to U.S. cell sites have fueled discussion of potential new tower-leasing demand for Crown Castle as SpaceX expands its wireless network. Traders see a possible growth opportunity, but debate the plans feasibility and emphasize that no agreement has been confirmed.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Anthropics IPO filing is driving attention to DXYZ as a public-market proxy for the private AI company. Traders are split: some see the IPO as a catalyst, while others cite concerns about Anthropics financial disclosures and DXYZs weak share-price response despite the filing.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys stronger parks performance and improving streaming profitability in its quarterly update have fueled cautious optimism, with traders watching for a sustained breakout from the stocks long-running range. Skeptics remain focused on its sluggish share performance and question whether the operating momentum will translate into lasting gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cencora Gears Up to Report Q4 Results: How to Play the Stock?

COR's Q4 earnings are likely to benefit from strong specialty pharma demand and MSO growth, but pricing pressures and higher interest costs may weigh on results.

Unveiling Cencora (COR) Q4 Outlook: Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.

Will Biodesix, Inc. (BDSX) Report Negative Earnings Next Week? What You Should Know

Biodesix (BDSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth

Cencora (COR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network

COR's $2.4B acquisition of AON aims to expand its oncology services platform, strengthen community cancer care and support long-term growth.

Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years

Cencora (NYSE:COR) has outperformed the market over the past 5 years by 11.54% on an annualized basis producing an average annual return of 22.6%. Currently, Cencora has a market capitalization of $64.88 billion.read more...

Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology

Cencora, Inc. (NYSE: COR) today announced it has signed a definitive agreement to acquire American Oncology Network, Inc. (AON) (OTCQX: AONC), a physician-led network of more than 350 oncology providers across 21 states. The acquisition of AON will expand our physician-led oncology MSO and support...

Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2026 on Wednesday, November 4, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on...

$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today

Cencora (NYSE:COR) has outperformed the market over the past 5 years by 8.44% on an annualized basis producing an average annual return of 20.45%. Currently, Cencora has a market capitalization of $57.98 billion.read more...

Cencora Elects Robert E. Sanchez to Its Board of Directors

Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026. Mr. Sanchez is the Executive Chair of Ryder System, Inc., where he previously served as Chair and Chief Executive Officer until his...

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Cencora Inc.

Cencora Announces $1B Investment In US After Q4 Numbers Beat Estimates

Equity

Neutral Sentiment

<p>Pharmaceutical solutions company Cencora (COR) announced on Wednesday that it intends to invest $1 billion through 2030 in the U.S. to expand its drug distribution network. &nbsp;</p><p>The company will open its second national distribution center in Ohio and expand its presence in both Alabama and California, it <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cencora.com/newsroom/cencora-to-invest-1-billion-in-us-distribution-network">said</a>.</p><h2 class="st-heading-2">Expansion Efforts</h2><p>The 530,000 square-foot national distribution center in Harrison, Ohio, is expected to be fully operational by spring 2027. It is expected to increase Cencora’s storage capacity and throughput significantly.</p><p>The company also plans to open a 430,000-square-foot distribution center in Fontana, California, which is expected to be fully operational by fall 2026, in addition to expanding its distribution center in Dothan, Alabama, dedicated to specialty medicines.</p><p>Specialty pharmaceuticals are used to treat complex, chronic, or rare medical conditions, and growth in this category of pharmaceuticals raises demand for specialized supply chain logistics, as many require cold chain storage, the company noted.</p><p>The expansion of the Dothan facility is expected to be completed by fall 2026. It aims to increase the facility’s refrigerated storage capacity by 500% and its frozen storage capacity by 200% to support the storage of specialty medicines.</p><h2 class="st-heading-2">Q4 Earnings And Guidance</h2><p>Cencora on Wednesday <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251105392361/en/Cencora-Reports-Fiscal-2025-Fourth-Quarter-and-Fiscal-Year-End-Results">reported</a> fourth-quarter revenue of $83.7 billion, up 5.9% year-over-year, thanks to robust growth in the U.S. healthcare solutions segment, and above an analyst estimate of $83.35 billion, according to data from Fiscal AI.</p><p>Adjusted and diluted earnings came in at $3.84 in the quarter, beating a Wall Street estimate of $3.82.</p><p>In fiscal year 2026, the company expects its overall revenue to grow by 5% to 7% and adjusted earnings per share in the range of $17.45 to $17.75, up from the $16 reported in fiscal year 2025, and in line with a $17.50 estimate.</p><h2 class="st-heading-2">How Did Stocktwits User React?</h2><p>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/COR">COR stock</a> rose from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.</p><p>COR stock is up 53% this year and approximately 47% over the past 12 months.&nbsp;</p><p>Read also: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-looks-to-hire-senior-insurance-claims-specialist-to-manage-incident-reporting-for-robotaxis/cL2q1zKREGS">Tesla Looks To Hire Senior Insurance Claims Specialist To Manage Incident Reporting For Robotaxis</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Cencora logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

The company will open its second national distribution center in Ohio and expand its presence in both Alabama and California, it said.

Dimensional ETF Trust - Dimensional US High Profitability ETF

Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

COR News